Clinical and economic impact of low-molecular weight heparins in managed care. Introduction.
D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D008329:Managed Care Programs; D011183:Postoperative Complications / Q000188:drug therapy / Q000517:prevention & control; D011655:Pulmonary Embolism / Q000188:drug therapy* / Q000517:prevention & control; D020246:Venous Thrombosis / Q000188:drug therapy* / Q000517:prevention & control
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight